Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

PT Kalbe Farma Tbk

PTKFF
Current price
0.11 USD 0 USD (0.00%)
Last closed 0.087 EUR
Company
ISIN ID1000125107
Sector Healthcare
Industry Drug Manufacturers - General
Exchange F
Capitalization 4 574 008 418 EUR
Yield for 12 month +5.00 %
1Y
3Y
5Y
10Y
15Y
PTKFF
21.11.2021 - 28.11.2021

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Address: Gedung KALBE, Jakarta, Indonesia, 10510

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

36793.71 %

Current Year

+1 780 224 912 EUR

Last Year

+1 691 612 710 EUR

Current Quarter

+465 691 025 EUR

Last Quarter

+488 948 943 EUR

Current Year

+691 252 375 EUR

Last Year

+684 237 772 EUR

Current Quarter

+183 769 197 EUR

Last Quarter

+194 181 126 EUR

Key Figures PTKFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 637 408 418 749 EUR
Operating Margin TTM 13.55 %
PE Ratio
Return On Assets TTM 8.88 %
PEG Ratio 1.8083
Return On Equity TTM 13.65 %
Wall Street Target Price
Revenue TTM 31 428 120 445 446 EUR
Book Value 468.96 EUR
Revenue Per Share TTM
Dividend Share 30.83 EUR
Quarterly Revenue Growth YOY 9 %
Dividend Yield 36793.71 %
Gross Profit TTM 9 571 770 697 042 EUR
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 26 %
Profit Margin 9.63 %

Dividend Analytics PTKFF

Dividend growth over 5 years

52 %

Continuous growth

7 years

Payout Ratio 5 years average

804520 %

Dividend History PTKFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 29.05.2024
Forward Annual Dividend Yield 2.02 %
Last Split Factor 5:1
Payout Ratio 47.06 %
Last Split Date 08.10.2012
Dividend Date

Stock Valuation PTKFF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 19.7239
Enterprise Value Revenue 2.2812
Price Sales TTM 0.0001
Enterprise Value EBITDA 16.2205
Price Book MRQ 3.1438

Financials PTKFF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PTKFF

For 52 weeks

0.063 EUR 0.1 EUR
50 Day MA 0.091 EUR
Shares Short Prior Month
200 Day MA 0.082 EUR
Short Ratio
Shares Short
Short Percent